Cancer Family
Mesenchymal Cell Neoplasm
CI-CAN-00000027Explore in graph →
Non-malignant413 active trials10 approved drugs208 evidence items
- NCIt
- C7059
Loading cancer entity…
Cancer Family
CI-CAN-00000027Explore in graph →
Clinical trials
1,848 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06617572 | Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel | available | — | — | USWM CT, LLCINDUSTRY | 1 | Aug 11, 2026 | clinicaltrials |
| NCT04571229 | Expanded Access Use of L-MTP-PE for the Treatment of Osteosarcoma | available | — | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 11, 2026 | clinicaltrials |
| NCT05041036 |
| Individual Patient Compassionate Use of Nirogacestat |
| available |
| — |
| — |
| SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, GermanyINDUSTRY |
| 0 |
| May 8, 2026 |
| clinicaltrials |
| NCT07497984 | ITM11 Expanded Access Program | available | — | — | ITM Solucin GmbHINDUSTRY | 0 | Mar 27, 2026 | clinicaltrials |
| NCT04091295 | BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast | available | — | — | Aveni FoundationOTHER | 1 | Mar 4, 2026 | clinicaltrials |
Data updated 22 days agoSource updated Aug 11, 2026source: clinicaltrials